Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma

Digestive and Liver Disease

Volumn 39, Issue 8, 2007, Pages 725-732

  Tachibana, M ^a   Tonomoto, Y ^a   Hyakudomi, R ^a   Hyakudomi, M ^a   Hattori, S ^a   Ueda, S ^a   Kinugasa, S ^a   Yoshimura, H ^a  

^a Faculty of Medicine   (Japan)

Author keywords

Eph receptor; Ephrin; Oesophageal cancer; Tyrosine kinase

Indexed keywords

EPHRIN B2; EPHRIN RECEPTOR B4; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RECONSTRUCTION; ESOPHAGUS RESECTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UPREGULATION;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EPHRIN-B2; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPHB4; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34447284784     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.05.013     Document Type: Article

References (36)

1. Iizuka T., Isono K., Kakegawa T., and Watanabe H. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96 (1989) 1005-1101
2. Daly J.M., Karnell L.H., and Menck H.R. National cancer data base report on esophageal carcinoma. Cancer 78 (1996) 1820-1828
3. Tachibana M., Kinugasa S., Yoshimura H., Dipok K.D., and Nagasue N. Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 138 (2003) 1383-1389
4. Surawska H., Ma P.C., and Salgia R. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15 (2004) 419-433
5. Davis S., Gale N.W., Aldrich T.H., Maisonpeirre P.C., Lothak V., Pawson T., et al. Ligands for Eph-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266 (1994) 816-819
6. Bruckner K., Pasquale E.B., and Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275 (1997) 1640-1643
7. Hirai H., Maru Y., Hagiwara K., Nishida J., and Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science 238 (1987) 1717-1720
8. Brantley-Sieders D., Schmidt S., Parker M., and Chen J. Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr Pharm Des 10 (2004) 3431-3442
9. Augustin H.G., and Reiss Y. EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasis. Cell Tissue Res 314 (2003) 25-31
10. Bennett B.D., Zeigler F.C., Gu Q., Fendly B., Goddard A.D., Gillett N., et al. Molecular cloning of a ligand for the eph-related receptor protein-tyrosine kinase Htk. Proc Natl Acad Sci USA 92 (1995) 1866-1870
11. Nikolova Z., Djonov V., Zuercher G., Andres A.C., and Ziemiecki A. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 111 (1998) 2741-2751
12. Steube K.G., Meyer C., Habig S., Uphoff C.C., and Drexler H.G. Expression of receptor tyrosine kinase HTK (hepatoma transmembrane kinase) and HTK ligand by human leukemia-lymphoma cell lines. Leuk Lymphoma 33 (1999) 371-376
13. Takai N., Miyazaki T., Fujisawa K., Nasu K., and Miyakawa I. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol Rep 8 (2001) 567-573
14. Miyazaki T., Kato H., Fukuchi M., Nakajima M., and Kuwano H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103 (2003) 657-663
15. Xu F., Zhong W., Li J., Shanshen Z., Cui J., Nesland J.M., et al. Predictive value of EphA2 and ephrin-A1 expression in oesophageal squamous cell carcinoma. Anticancer Res 25 (2005) 2943-2950
16. Fleming I.D., and American Joint Committee on Cancer Classification (AJCC). AJCC cancer staging manual (1997), Lippincott, Philadelphia
17. Kaplan E.L., and Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 53 (1958) 457-481
18. Nakamura R., Kataoka H., Sato N., Kanamori M., Ihara M., Igarashi H., et al. EphA2/EFNA1 expression in human gastric cancer. Cancer Sci 96 (2005) 42-47
19. Liu W., Ahmad S.A., Jung Y.D., Reinmuth N., Fan F., Buncana C.D., et al. Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer 94 (2002) 934-939
20. Liu W., Jung Y.D., Ahmad S.A., McCarty M.F., Stoeltzing O., Reinmuth N., et al. Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. Br J Cancer 90 (2004) 1620-1626
21. Duxbury M.S., Ito H., Zinner M.J., Ashley S.W., and Whang E.E. Ligation of EphA2 by ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Biochem Biophys Res Commun 6 (2004) 1096-1102
22. Berclaz G., Flutsch B., Altermatt H.J., Rohrbach V., Djonov V., Ziemiecki A., et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast. Oncol Rep 9 (2002) 985-989
23. Noblitt L.W., Bangari D.S., Shukla S., Knapp D.W., Mohammed S., Kinch M.S., et al. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express ephrinA1. Cancer Gene Ther 11 (2004) 757-766
24. Wu Q., Suo Z., Risberg B., Karlsson M.G., Villman K., and Nesland J.M. Expression of EphB2 and EphB4 in breast carcinoma. Pathol Oncol Res 10 (2004) 26-33
25. Berclaz G., Karamitopoulou E., Mazzucchelli L., Rohrbach V., Dreher E., Ziemiechi A., et al. Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma. Ann Oncol 14 (2003) 220-226
26. Takai N., Ueda T., Nishida M., Nasu K., and Miyakawa I. The relationship between oncogene expression and clinical outcome in endometrial carcinoma. Curr Cancer Drug Targets 4 (2004) 511-520
27. Wu D., Suo Z., Kristensen G.B., Li S., Troen G., Holm R., et al. Prognostic value of EphA2 and ephrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol 94 (2004) 312-319
28. Tang X.X., Evans A.E., Zhao H., Cnaan A., London W., Cohn S.L., et al. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastoma. Clin Cancer Res 5 (1999) 1491-1496
29. Tang X.X., Zhao H., Robinson M.E., Cohen B., Cnaan A., London W., et al. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci USA 97 (2000) 10936-10941
30. Kinch M.S., Moore M.B., and Harpole D.H. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 9 (2003) 613-618
31. Vogt T., Stolz W., Welsh J., Jung B., Kerbel R.S., Kobayashi H., et al. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res 4 (1998) 791-797
32. Easty D.J., Hill S.P., Hsu M.Y., Fallowfield M.E., Florenes V.A., Herlyn M., et al. Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer 84 (1999) 494-501
33. Masood R., Xia G., Smith D.L., Scalla P., Still J.G., Tulpule A., et al. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood 105 (2005) 1310-1318
34. Heroult M., Schaffner F., and Augustin H.G. Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312 (2006) 642-650
35. Tachibana M., Yoshimura H., Kinugasa S., Dhar D.K., Shibakita M., Ohno S., et al. Clinicophathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Dig Liver Dis 33 (2001) 354-358
36. Sugimachi K., Sumiyoshi K., Nozoe T., Yasuda M., Watanabe M., Kitamura K., et al. Carcinogenesis and histogenesis of esophageal carcinoma. Cancer 75 (1995) 1440-1445